Literature DB >> 8198438

Comparison of three different recombinant hepatitis B virus core particles expressed in Escherichia coli.

A Maassen1, A Rehfeldt, S Kiessig, A Ladhoff, W E Höhne, H Meisel.   

Abstract

The properties of three different recombinant hepatitis B virus core proteins expressed in Escherichia coli were compared: an N-terminal fusion protein, a C-terminally truncated protein and a sequence-authentic protein. All three proteins assembled into capsid-like particles with typical HBc-antigenicity, sedimentation behavior and distinctive electron microscopical images. Apart from this, however, variant HBc proteins displayed properties different from sequence-authentic HBc protein p21.4. Unlike p21.4, the particles of the N-terminal fusion protein p22.2 were sensitive to proteolytic attack by trypsin at variable sites within its arginine-rich C-terminus but not in its extended N-terminus. We therefore conclude that the C-terminal region is located on the surface of the p22.2 particle. These particles also showed increased HBe-antigenicity, as did the C-terminally truncated core particles p17.6, and to an even greater extent p18* particles which were derived from p22.2 by tryptic digestion. This might be interpreted as evidence for an--albeit minor--structural change. All variant core particles were less stable and contained less RNA. Electron microscopic indication for DNA binding of C-terminal deleted p17.6 particles was obtained using an aqueous spreading technique.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198438     DOI: 10.1007/bf01309770

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  26 in total

1.  A routine method for protein-free spreading of double- and single-stranded nucleic acid molecules.

Authors:  H J Vollenweider; J M Sogo; T Koller
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

2.  Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface.

Authors:  G P Borisova; I Berzins; P M Pushko; P Pumpen; E J Gren; V V Tsibinogin; V Loseva; V Ose; R Ulrich; H Siakkou
Journal:  FEBS Lett       Date:  1989-12-18       Impact factor: 4.124

3.  New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants.

Authors:  L O Magnius; J A Espmark
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen.

Authors:  J H Ou; O Laub; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.

Authors:  M Imai; M Nomura; T Gotanda; T Sano; K Tachibana; H Miyamoto; K Takahashi; S Toyama; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

7.  The quaternary structure, antigenicity, and aggregational behavior of the secretory core protein of human hepatitis B virus are determined by its signal sequence.

Authors:  H J Schlicht; G Wasenauer
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

9.  DNA-binding activity of hepatitis B e antigen polypeptide lacking the protaminelike sequence of nucleocapsid protein of human hepatitis B virus.

Authors:  K Matsuda; S Satoh; H Ohori
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

10.  Cys residues of the hepatitis B virus capsid protein are not essential for the assembly of viral core particles but can influence their stability.

Authors:  S Zhou; D N Standring
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.